Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Trastuzumab, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Trastuzumab Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Trastuzumab Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Trastuzumab Market Size Growth Rate by Type
    • 1.4.2 Human Source
    • 1.4.3 Animal Source
  • 1.5 Market by Application
    • 1.5.1 Global Trastuzumab Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Medical Center
  • 1.6 Coronavirus Disease 2019 (Covid-19): Trastuzumab Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Trastuzumab Industry
      • 1.6.1.1 Trastuzumab Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Trastuzumab Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Trastuzumab Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Trastuzumab Market Size Estimates and Forecasts
    • 2.1.1 Global Trastuzumab Revenue 2015-2026
    • 2.1.2 Global Trastuzumab Sales 2015-2026
  • 2.2 Trastuzumab Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Trastuzumab Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Trastuzumab Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Trastuzumab Competitor Landscape by Players

  • 3.1 Trastuzumab Sales by Manufacturers
    • 3.1.1 Trastuzumab Sales by Manufacturers (2015-2020)
    • 3.1.2 Trastuzumab Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Trastuzumab Revenue by Manufacturers
    • 3.2.1 Trastuzumab Revenue by Manufacturers (2015-2020)
    • 3.2.2 Trastuzumab Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Trastuzumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Trastuzumab Revenue in 2019
    • 3.2.5 Global Trastuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Trastuzumab Price by Manufacturers
  • 3.4 Trastuzumab Manufacturing Base Distribution, Product Types
    • 3.4.1 Trastuzumab Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Trastuzumab Product Type
    • 3.4.3 Date of International Manufacturers Enter into Trastuzumab Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Trastuzumab Market Size by Type (2015-2020)
    • 4.1.1 Global Trastuzumab Sales by Type (2015-2020)
    • 4.1.2 Global Trastuzumab Revenue by Type (2015-2020)
    • 4.1.3 Trastuzumab Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Trastuzumab Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Trastuzumab Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Trastuzumab Revenue Forecast by Type (2021-2026)
    • 4.2.3 Trastuzumab Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Trastuzumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Trastuzumab Market Size by Application (2015-2020)
    • 5.1.1 Global Trastuzumab Sales by Application (2015-2020)
    • 5.1.2 Global Trastuzumab Revenue by Application (2015-2020)
    • 5.1.3 Trastuzumab Price by Application (2015-2020)
  • 5.2 Trastuzumab Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Trastuzumab Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Trastuzumab Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Trastuzumab Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Trastuzumab by Country
    • 6.1.1 North America Trastuzumab Sales by Country
    • 6.1.2 North America Trastuzumab Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Trastuzumab Market Facts & Figures by Type
  • 6.3 North America Trastuzumab Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Trastuzumab by Country
    • 7.1.1 Europe Trastuzumab Sales by Country
    • 7.1.2 Europe Trastuzumab Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Trastuzumab Market Facts & Figures by Type
  • 7.3 Europe Trastuzumab Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Trastuzumab by Region
    • 8.1.1 Asia Pacific Trastuzumab Sales by Region
    • 8.1.2 Asia Pacific Trastuzumab Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Trastuzumab Market Facts & Figures by Type
  • 8.3 Asia Pacific Trastuzumab Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Trastuzumab by Country
    • 9.1.1 Latin America Trastuzumab Sales by Country
    • 9.1.2 Latin America Trastuzumab Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Trastuzumab Market Facts & Figures by Type
  • 9.3 Central & South America Trastuzumab Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Trastuzumab by Country
    • 10.1.1 Middle East and Africa Trastuzumab Sales by Country
    • 10.1.2 Middle East and Africa Trastuzumab Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Trastuzumab Market Facts & Figures by Type
  • 10.3 Middle East and Africa Trastuzumab Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Genentech Inc
    • 11.1.1 Genentech Inc Corporation Information
    • 11.1.2 Genentech Inc Description, Business Overview and Total Revenue
    • 11.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Genentech Inc Trastuzumab Products Offered
    • 11.1.5 Genentech Inc Recent Development
  • 11.2 Novartis AG
    • 11.2.1 Novartis AG Corporation Information
    • 11.2.2 Novartis AG Description, Business Overview and Total Revenue
    • 11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis AG Trastuzumab Products Offered
    • 11.2.5 Novartis AG Recent Development
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Description, Business Overview and Total Revenue
    • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pfizer Trastuzumab Products Offered
    • 11.3.5 Pfizer Recent Development
  • 11.4 Abnova Corporation
    • 11.4.1 Abnova Corporation Corporation Information
    • 11.4.2 Abnova Corporation Description, Business Overview and Total Revenue
    • 11.4.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Abnova Corporation Trastuzumab Products Offered
    • 11.4.5 Abnova Corporation Recent Development
  • 11.5 InvivoGen
    • 11.5.1 InvivoGen Corporation Information
    • 11.5.2 InvivoGen Description, Business Overview and Total Revenue
    • 11.5.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 InvivoGen Trastuzumab Products Offered
    • 11.5.5 InvivoGen Recent Development
  • 11.6 Celltrion
    • 11.6.1 Celltrion Corporation Information
    • 11.6.2 Celltrion Description, Business Overview and Total Revenue
    • 11.6.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Celltrion Trastuzumab Products Offered
    • 11.6.5 Celltrion Recent Development
  • 11.7 Biocon Limited
    • 11.7.1 Biocon Limited Corporation Information
    • 11.7.2 Biocon Limited Description, Business Overview and Total Revenue
    • 11.7.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Biocon Limited Trastuzumab Products Offered
    • 11.7.5 Biocon Limited Recent Development
  • 11.8 Bio-Techne
    • 11.8.1 Bio-Techne Corporation Information
    • 11.8.2 Bio-Techne Description, Business Overview and Total Revenue
    • 11.8.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Bio-Techne Trastuzumab Products Offered
    • 11.8.5 Bio-Techne Recent Development
  • 11.1 Genentech Inc
    • 11.1.1 Genentech Inc Corporation Information
    • 11.1.2 Genentech Inc Description, Business Overview and Total Revenue
    • 11.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Genentech Inc Trastuzumab Products Offered
    • 11.1.5 Genentech Inc Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Trastuzumab Market Estimates and Projections by Region
    • 12.1.1 Global Trastuzumab Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Trastuzumab Revenue Forecast by Regions 2021-2026
  • 12.2 North America Trastuzumab Market Size Forecast (2021-2026)
    • 12.2.1 North America: Trastuzumab Sales Forecast (2021-2026)
    • 12.2.2 North America: Trastuzumab Revenue Forecast (2021-2026)
    • 12.2.3 North America: Trastuzumab Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Trastuzumab Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Trastuzumab Sales Forecast (2021-2026)
    • 12.3.2 Europe: Trastuzumab Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Trastuzumab Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Trastuzumab Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Trastuzumab Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Trastuzumab Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Trastuzumab Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Trastuzumab Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Trastuzumab Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Trastuzumab Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Trastuzumab Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Trastuzumab Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Trastuzumab Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Trastuzumab Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Trastuzumab Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Trastuzumab Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Trastuzumab Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Trastuzumab market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Trastuzumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Trastuzumab market is segmented into
    Human Source
    Animal Source

    Segment by Application, the Trastuzumab market is segmented into
    Hospital
    Medical Center

    Regional and Country-level Analysis
    The Trastuzumab market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Trastuzumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Trastuzumab Market Share Analysis
    Trastuzumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Trastuzumab business, the date to enter into the Trastuzumab market, Trastuzumab product introduction, recent developments, etc.
    The major vendors covered:
    Genentech Inc
    Novartis AG
    Pfizer
    Abnova Corporation
    InvivoGen
    Celltrion
    Biocon Limited
    Bio-Techne

    Buy now